BioCorRx (BICX) Change in Accured Expenses (2011 - 2026)
BioCorRx (BICX) posted Change in Accured Expenses of $253990.0 for Q1 2026, up 116.58% sequentially from -$1.5 million in Q4 2025, and up 1455.07% YoY from $16333.0 in Q1 2025.
BioCorRx (BICX) Change in Accured Expenses (2011 - 2026) Analysis & Trends
BioCorRx has reported Change in Accured Expenses for 13 years, with the latest figure at $253990.0 in Q1 2026.
- Quarterly Change in Accured Expenses rose 1455.07% year-over-year to $253990.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $524496.0 (down 53.62% YoY) and the FY2025 annual result came in at $286839.0, down 80.11% from the prior year.
- Change in Accured Expenses advanced to $253990.0 in Q1 2026 per BICX's latest filing, from -$1.5 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $934022.0 in Q2 2025 and troughed at -$1.5 million in Q4 2025.
- A 5-year average of $213186.9 and a median of $243702.0 in 2023 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2025 and 2026: Change in Accured Expenses plunged 24994.32% in 2025, then jumped 1455.07% in 2026.
- Over 5 years, Change in Accured Expenses stood at $163767.0 in 2022, then increased by 25.55% to $205612.0 in 2023, then plunged by 102.97% to -$6106.0 in 2024, then slumped by 24994.32% to -$1.5 million in 2025, then soared by 116.58% to $253990.0 in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $253990.0, -$1.5 million, and $868743.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | 551.00 Mn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | -493.00 Mn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | -22.40 Mn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | -11.42 Mn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 145.62 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 94.87 Mn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 18.28 Mn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 4.48 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | - |
| 10 | BioCorRx | 1.49 Mn | 1.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 253,990.00 |
| Mar 31, 2026 | 253,990.00 |
| Dec 31, 2025 | -1.53 Mn |
| Dec 31, 2025 | -1.53 Mn |
| Sep 30, 2025 | 868,743.00 |
| Sep 30, 2025 | 868,743.00 |
| Jun 30, 2025 | 934,022.00 |
| Jun 30, 2025 | 934,022.00 |
| Mar 31, 2025 | 16,333.00 |
| Mar 31, 2025 | 16,333.00 |
| Dec 31, 2024 | -6,106.00 |
| Dec 31, 2024 | -6,106.00 |
| Sep 30, 2024 | 404,534.00 |
| Sep 30, 2024 | 404,534.00 |
| Jun 30, 2024 | 716,136.00 |
| Jun 30, 2024 | 716,136.00 |
| Mar 31, 2024 | 327,596.00 |
| Mar 31, 2024 | 327,596.00 |
| Dec 31, 2023 | 205,612.00 |
| Dec 31, 2023 | 205,612.00 |